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Conclusions: Immediate BMV results for ideal patients with pliable valves
and non-ideal patients who would otherwise be MVR candidates are good.
Three year event free survival is excellent in ideal patients. Non-ideal patients
with significant valve deformity have freedom from death, MVR or repeat
PTMC after three years in 62% of cases.
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1717-41 8alloon Valvotomy for Non-Ideal Commissurotomy
Candidates
Ted Feldman, Howard C. Herrmann, John D. Carroll, K. Ramaswamy. Jonathan
M. Tob;s, J. Kevin Harrison, Augusto D. Pichard, David R. Holmes, Donald
A. Rothbaum, Gerald Dorres, Steven R. Bailey, Robert Feldman, James
R. Margolis, Stephen R. Ramee, N. American Inoue Investigation. University of
Chicago, Chicago, IL
Results for balloon mitral valvotomy (BMV) are usually reported for large het-
erogenous groups. Different outcomes are expected for good commissuro-
tomy candidates (Ideal) compared to patients with significant valve deformity
who might otherwise be good MVR candidates (Non-Ideal). We defined Ideal
as echo score ~6 and Non-Ideal as score 2:9/age ~72.
n
Age (years)
NYHA
Echo Score
MVA pre-+post
MVR 30 days
3 Yr. Event Free
, ~ p < 0.01 vs Ideal
Ideal Patients
334
47 ± 12
2.8 ± 0.7
48±1.4
1 ± 0.3-+1.8 ± 0.6
5.2%
82%
Non-Ideal Patients
154
54 ± 11'
2.9 ± 0.6
10.1 ± 1.3'
1 ± 0.3-+1.7 ± 06'
8.1%
62%*
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1717-61 Indications, Complications and Mid-term Outcome of
Percutaneous 8alloon Mitral Valvotomy During
Pregnancy
Mohamed Ben Farhat, Fethi Batbout, Faouzi Maatouk, Mokdad Ayari,
Habib Gamra, Mourad Jarrar. University Hospital. Monastir; Tunisia
We performed double balloon mitral valvotomy (BMV) in 36 consecutive
pregnant women (mean age 26 years). Pregnancy mean age was 26 weeks
(range 14--38 weeks). Thirty patients (pts) had pliable valves, 4 pts semi pli-
able valves and 2 pts calcific valves at fluoroscopy. Four pts had moderately
severe MS (MVA 1.4 to 1.7 cm2). Moderate (2+1 mitral regurgitation (MR)
was present in 2 pts. Thirty pts were in NYHA functional class III or IV and 6
pts were in class II. The patient's pelvic-abdominal area was shield. Double
balloon technique was used in 35 pts and Inoue device in one pt. The total
mean time of BMV was 76 ± 19 min and that of fluoroscopy was 18 ± 8 min.
Left atrium pressure decreased from 28 ± 9 to 14 ± 5 mmHg, cardiac index
increased from 3.2 ± 0.9 to 4.6 ± 1 IImn/m 2 and MVA increased from 0.9
± 0.2 to 2.5 ± 0.4 cm 2 There were no mortality nor residual MS. Impres-
sive symptomatic improvement was obtained in all pts but 1 who developed
severe (4+) MR and underwent mitral valve replacement 5 days later. Thirty
three pts delivered at full-term, 31 pts delivered vaginally and 2 pts by ce-
sarean section due to obstetrical problems; 30 babies were normal and 3
were hypotrophic. At mean 24 ± 11 months post partum follow-up, the 33
infants had shown normal growth and development. Pregnancy evolves nor-
mally in the 3 remaining pts.
Conclusion: During pregnancy BMV is the treatment of choice of severe
pliable MS. Indications may be broadened to pts with rigid and calcific valves
and to pts who had moderately severe MS or associated moderate MR and
refractory disability.
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1717-51 Comparison of Six Year Follow-up Results of 8alloon
Mitral Valvotomy in Patients with and without Mitral
Regurgitation
He Ping Zhang, John W. Allen, Francis YK. Lau, Carlos E. Ruiz. Lama Linda
University School ofMedicine, Lama Unda, CA
Previous studies have demonstrated that mitral regurgitation (MR) greatly
influenced long-term outcome after surgical mitral commissurotomy in pts
with mitral stenosis. However, this issue has not been addressed after bal-
loon mitral valvotomy (BMV). We therefore examined 6 year follow-up (FU)
data in 69 pts who presented MR assessed by angiography before BMV
(group 1). and compared the results with 75 pts who had no MR (group 2).
Mean FU period was 27 ± 20 mo in group 1 and 33 ± 23 mo in group 2 (p
= NS). Comparison of pts baseline characteristics, mitral valve area (MVA)
before and after BMV and FU results between the groups were:
Clinical Profile Group 1 Group 2 p-value
Age Iyr) 57 ± 13 45 ± 16 0.0001
Sex: M/F 80%/20% 17%/83% NS
NYHA-FC: III-IV 90% 81% NS
Echo score >8 22% 12% NS
Fluoroscopic Ca2+ 87% 60% 0.001
A.F 56% 19% 00001
Pre 2D MVA (cm2) 1.06 ± 0.30 100 ± 027 NS
Post 2D MVA Icm2) 1.71 ± 0.35 1.88±0.41 001
FU NYHA class I 51% 88% 00001
Cardiac events ICE) 28% 9% <0.01
CE = stroke. repeat BM'/. mitral valve replacement IMVRI. and death
Comparison of 6 year CE-free and MVR-free actuarial survival rates were:
Gr 1 I Gr 2 1-yr 2-yr 3-yr 4-yr 5-yr 6-yr p-value
CE-free (%) 87/94 79/92 73190 65/90 59/90 49/79 0002
MVR-free (%) 93/96 89/96 82/96 78/96 78/96 65/84 0.01
Hazard risk ratio by Cox regression analysis was 3.7 (95% CI: 1.5-8.9)
times greater for CE (p < 0.01), and 4.0 (1.2-12.7) times greater for MVR (p
< 0.05) at FU in group 1 than in group 2. Conclusions: (1) MR before BMV in-
creases risk for late CE, particularly requiring MVR in the early FU. (21 Pts with
MR appears to be older with calcified valves and AF. and to obtain smaller
MVA post BMV, all of which may exacerbate the poor later outcome. (3) Half
of such pts may still derive long-term benefits from BMV
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1718-1 I Effect of Muscarinic Stimulation on Isovolumic
Relaxation in the Normal and Failing Human Left
Ventricle
Gary E. Newton, Anne M. Schofield, Wilson S. Colucci, John D. Parker. Brigham
and Women'S Hospital, Boston, MA; Mount Sinai Hospital, Toronto, Ontario, Canada
Myocardial muscarinic receptor stimulation attenuates the inotropic re-
sponse to Ii-adrenergic receptor stimulation in the normal and failing human
LV Its effect on isovolumic LV relaxation in humans is unknown.
Methods: We investigated 12 patients with congestive heart failure (CHF)
(EF 33 ± 3%1 and 6 patients with normal LV function (EF 71 ± 3%). Hemo-
dynamic responses (Millar) were measured during intracoronary infusion of
dobutamine (Dob) 25 /lg/min, acetylcholine (Ach) 1 /lM, and during the com-
bination of Dob and Ach.
Results: There were no changes in HR during drug infusions. Dob had a
positive inotropic effect. increasing LV +dP/dt by 662 ± 82 mmHg/s (p <
0.016) in the normal group, and by 284 ± 37 mmHg/s (p < 0.016) in the
CHF group. Dob also had a positive lusitropic effect. increasing isovolumic
LV relaxation and reducing LVEDP in both groups. During Ach there was no
change in LV +dP/dt or LV systolic pressure in either group. Ach caused a
small but consistent slowing of isovolumic LV relaxation in the CHF group,
which was associated with an increase in LVEDP Ach had no effect on T1/2
or TL in the normal group. The combination of Ach and Dob attenuated the
positive lusitropic response to Dob in both groups:
Can Dab Con-2 Ach Dob/Ach
NL: LVEDP 7± 1 6 ± 1* 7± 1 7± 1 5± 1
Tau 37 ± 3 32 ± 2* 36 ± 2 35 ± 3 35 ± 3
CHF: LVEDP 18 ± 3 15 ± 3* 18 ± 3 21 ± 3' 20 ± 3
Tau 54 ± 4 45 ± 3* 52 ± 2 56 ± 3' 53 ± 3
LVEOP in mmHg: Tau. TL in msec: *p < 0.016. All data mean ± SEM
Conclusions: This study demonstrates that muscarinic receptor stimula-
tion antagonizes the positive lusitropic effect of adrenergic stimulation in
both the normal and failing human LV Furthermore, in the failing human LV,
muscarinic receptor stimulation has a primary negative lusitropic effect.
